- Home
- RUMBW vs BRKRP Comparison
RUMBW vs BRKRP Comparison
Compare RUMBW & BRKRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RUMBW | BRKRP |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | 156 | 11085 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RUMBW | BRKRP |
|---|---|---|
| Price | $0.96 | $287.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 12.5K | 10.4K |
| Earning Date | 03-28-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,651,775.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $0.76 | $256.35 |
| 52 Week High | $4.25 | $419.83 |
Technical Indicators
Market Signals| Indicator | RUMBW | BRKRP |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 47.42 |
| Support Level | $0.90 | $260.32 |
| Resistance Level | $2.81 | $290.74 |
| Average True Range (ATR) | 0.11 | 4.61 |
| MACD | -0.01 | 2.73 |
| Stochastic Oscillator | 36.89 | 54.27 |
Price Performance
Historical ComparisonAbout RUMBW Rumble Inc. Warrant
Rumble Inc is a free-to-use video-sharing and livestreaming platform where users can watch, share, like, comment, and upload their own videos. Users can follow channels to stay in touch with creators and access video on-demand (VOD) and live content streamed by creators. Geographically, it generates a majority of its revenue from the United States.
About BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.